Aspen Aerogels, Inc. ( ASPN ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Neal Baranosky - Senior Director of Corporate of Strategy & Finance Donald Young - President, CEO & Director Grant Thoele - Treasurer & CFO Conference Call Participants Eric Stine - Craig-Hallum Capital Group LLC, Research Division Colin Rusch - Oppenheimer & Co. Inc., Research Division Ryan Pfingst - B. Riley Securities, Inc., Research Division John Anderson - Barclays Bank PLC, Research Division Leanne Hayden - Canaccord Genuity Corp., Research Division Presentation Operator Good morning.

INmune Bio (INMB) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Uber Technologies, Inc. delivered strong Q3 results with double-digit growth across sales, trips, and EBITDA, but shares fell 7% post-earnings. UBER's fundamentals remain robust, with cross-platform usage, new partnerships (Toast, Nvidia), and a shift toward value driving future growth. Concerns over softer Q4 guidance look overblown; consensus estimates for long-term EPS have actually been revised upward post-earnings.

Crude oil lost early gains after briefly breaking above $60, with resistance extending toward $62. I remain bearish, viewing short-term rallies as selling opportunities while global supply and economic concerns weigh on prices.

Nearly 30 locations planned by end of 2025 as Life Time builds on its leading small- and large-group training portfolio CHANHASSEN, Minn. , Nov. 6, 2025 /PRNewswire/ -- With demand for reformer-based workouts at record highs, Life Time (NYSE: LTH), the nation's premier healthy lifestyle brand, today announced the nationwide continued expansion of CTR (Core.

The Invesco S&P 500 Equal Weight Consumer Staples ETF offers equally weighted exposure to 37 consumer staples from the S&P 500. RSPS compares poorly to XLP on cost-efficiency, total returns, risk-adjusted metrics, and volatility, while it offers slightly cheaper valuation and potential for mean reversion. Q4 earnings growth expectations for staple stocks have taken a hit in recent days, implying limited pricing power and tariff pressure, while other S&P 500 stocks appear to be holding up well.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before November 17, 2025.

Investor Conference Call to be conducted on the same day at 4:30 p.m. Eastern JERICHO, NY / ACCESS Newswire / November 6, 2025 / Intelligent Protection Management Corp. ("IPM" or the "Company") (Nasdaq:IPM), a managed technology solutions provider focused on enterprise cybersecurity and cloud infrastructure, today announced today it will issue third quarter 2025 financial results on Wednesday, November 12, 2025, after the market close.

AppLovin Corp (NASDAQ:APP) was last seen up 0.5% to trade at $619.50, after the company posted better-than-expected third-quarter earnings of $2.45 per share on revenue of $1.41 billion and lifted its current-quarter revenue guidance.

Tech stocks are struggling for direction this morning, but don't tell Datadog Inc (NASDAQ:DDOG).

Entering 2025, one of the biggest market narratives investors faced was concentration risk. Despite tariffs coming and going with speed and stagflation a looming specter, concentration risk and the need for diversification continue to linger.

Farmland Partners gets a hold/neutral rating for my initial coverage, agreeing with today's consensus from analysts and the quant rating. This farmland REIT's upside potential is in its diversified national portfolio and potential future land values, but also low vacancy rates and scarcity of arable farmland for producing food. Other positives were FFO and operating cash flow growth, and a low debt-to-equity, but EBITDA margin and dividend growth could improve.

APD's Q4 earnings and revenue fell short of estimates, with lower volumes weighing on results despite regional gains and currency tailwinds.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.